Clinical outcome of pancreas transplantation from marginal donors in japan

Y. Tomimaru, T. Ito, K. Kawamoto, N. Hama, H. Wada, S. Kobayashi, Hidetoshi Eguchi, M. Tanemura, Masaki Mori, Y. Doki, H. Nagano

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In Japan, absolute shortage of donors still continues even after the law allowing organ transplantation from deceased donors came into force in 1997. With the passage of the waiting period after registration for pancreas transplantation (PTx), both deaths and serious cases of diabetic complications necessitating withdrawal of the registration have undoubtedly increased. Therefore, so-called "marginal donor" (MD) has been considered as a potential solution for shortage of donors in Japan. The aim of the present study is to evaluate feasibility of MD in terms of post-PTx outcomes using data from Japan Organ Transplantation Network. A total of 148 PTx were performed from deceased donors in Japan from 2000 to 2012. MD was defined as follows: (1) >45 years old; (2) hemodynamically unstable at harvest using a high-dose dopamine or more than 2 vasopressors; or (3) non-heart-beating status. Postoperative outcomes after PTx were compared between the MD group and the non-MD group. Among the 148 PTx donors, 108 donors (73.0%) satisfied the criteria of MD. Early graft loss of pancreas graft during 3 months post-transplant was observed in 15 patients (10.1%), and the marginality (MD vs non-MD) was not significantly correlated with the early loss of pancreas graft. The overall patient survival of the MD group (1, 3, 5 years: 94.7%, 94.7%, 94.7%) was not significantly different from that of the non-MD group (1, 3, 5 years: 95.0%, 95.0%, 95.0%). Pancreas graft survival in the MD group (1, 3, 5 years: 80.9%, 73.2%, 66.0%) seemed to be slightly lower than that in the non-MD group (1, 3, 5 years: 92.5%, 85.2%, 77.4%), but no statistically significant differences were found between the 2 groups. These results suggest the feasibility of the use of MD for PTx.

Original languageEnglish
Pages (from-to)954-957
Number of pages4
JournalTransplantation Proceedings
Volume46
Issue number3
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Pancreas Transplantation
Japan
Tissue Donors
Transplants
Pancreas
Organ Transplantation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Tomimaru, Y., Ito, T., Kawamoto, K., Hama, N., Wada, H., Kobayashi, S., ... Nagano, H. (2014). Clinical outcome of pancreas transplantation from marginal donors in japan. Transplantation Proceedings, 46(3), 954-957. https://doi.org/10.1016/j.transproceed.2013.11.069

Clinical outcome of pancreas transplantation from marginal donors in japan. / Tomimaru, Y.; Ito, T.; Kawamoto, K.; Hama, N.; Wada, H.; Kobayashi, S.; Eguchi, Hidetoshi; Tanemura, M.; Mori, Masaki; Doki, Y.; Nagano, H.

In: Transplantation Proceedings, Vol. 46, No. 3, 01.01.2014, p. 954-957.

Research output: Contribution to journalArticle

Tomimaru, Y, Ito, T, Kawamoto, K, Hama, N, Wada, H, Kobayashi, S, Eguchi, H, Tanemura, M, Mori, M, Doki, Y & Nagano, H 2014, 'Clinical outcome of pancreas transplantation from marginal donors in japan', Transplantation Proceedings, vol. 46, no. 3, pp. 954-957. https://doi.org/10.1016/j.transproceed.2013.11.069
Tomimaru, Y. ; Ito, T. ; Kawamoto, K. ; Hama, N. ; Wada, H. ; Kobayashi, S. ; Eguchi, Hidetoshi ; Tanemura, M. ; Mori, Masaki ; Doki, Y. ; Nagano, H. / Clinical outcome of pancreas transplantation from marginal donors in japan. In: Transplantation Proceedings. 2014 ; Vol. 46, No. 3. pp. 954-957.
@article{72fc1b7dcece423296dfee4ecf04ba65,
title = "Clinical outcome of pancreas transplantation from marginal donors in japan",
abstract = "In Japan, absolute shortage of donors still continues even after the law allowing organ transplantation from deceased donors came into force in 1997. With the passage of the waiting period after registration for pancreas transplantation (PTx), both deaths and serious cases of diabetic complications necessitating withdrawal of the registration have undoubtedly increased. Therefore, so-called {"}marginal donor{"} (MD) has been considered as a potential solution for shortage of donors in Japan. The aim of the present study is to evaluate feasibility of MD in terms of post-PTx outcomes using data from Japan Organ Transplantation Network. A total of 148 PTx were performed from deceased donors in Japan from 2000 to 2012. MD was defined as follows: (1) >45 years old; (2) hemodynamically unstable at harvest using a high-dose dopamine or more than 2 vasopressors; or (3) non-heart-beating status. Postoperative outcomes after PTx were compared between the MD group and the non-MD group. Among the 148 PTx donors, 108 donors (73.0{\%}) satisfied the criteria of MD. Early graft loss of pancreas graft during 3 months post-transplant was observed in 15 patients (10.1{\%}), and the marginality (MD vs non-MD) was not significantly correlated with the early loss of pancreas graft. The overall patient survival of the MD group (1, 3, 5 years: 94.7{\%}, 94.7{\%}, 94.7{\%}) was not significantly different from that of the non-MD group (1, 3, 5 years: 95.0{\%}, 95.0{\%}, 95.0{\%}). Pancreas graft survival in the MD group (1, 3, 5 years: 80.9{\%}, 73.2{\%}, 66.0{\%}) seemed to be slightly lower than that in the non-MD group (1, 3, 5 years: 92.5{\%}, 85.2{\%}, 77.4{\%}), but no statistically significant differences were found between the 2 groups. These results suggest the feasibility of the use of MD for PTx.",
author = "Y. Tomimaru and T. Ito and K. Kawamoto and N. Hama and H. Wada and S. Kobayashi and Hidetoshi Eguchi and M. Tanemura and Masaki Mori and Y. Doki and H. Nagano",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.transproceed.2013.11.069",
language = "English",
volume = "46",
pages = "954--957",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Clinical outcome of pancreas transplantation from marginal donors in japan

AU - Tomimaru, Y.

AU - Ito, T.

AU - Kawamoto, K.

AU - Hama, N.

AU - Wada, H.

AU - Kobayashi, S.

AU - Eguchi, Hidetoshi

AU - Tanemura, M.

AU - Mori, Masaki

AU - Doki, Y.

AU - Nagano, H.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - In Japan, absolute shortage of donors still continues even after the law allowing organ transplantation from deceased donors came into force in 1997. With the passage of the waiting period after registration for pancreas transplantation (PTx), both deaths and serious cases of diabetic complications necessitating withdrawal of the registration have undoubtedly increased. Therefore, so-called "marginal donor" (MD) has been considered as a potential solution for shortage of donors in Japan. The aim of the present study is to evaluate feasibility of MD in terms of post-PTx outcomes using data from Japan Organ Transplantation Network. A total of 148 PTx were performed from deceased donors in Japan from 2000 to 2012. MD was defined as follows: (1) >45 years old; (2) hemodynamically unstable at harvest using a high-dose dopamine or more than 2 vasopressors; or (3) non-heart-beating status. Postoperative outcomes after PTx were compared between the MD group and the non-MD group. Among the 148 PTx donors, 108 donors (73.0%) satisfied the criteria of MD. Early graft loss of pancreas graft during 3 months post-transplant was observed in 15 patients (10.1%), and the marginality (MD vs non-MD) was not significantly correlated with the early loss of pancreas graft. The overall patient survival of the MD group (1, 3, 5 years: 94.7%, 94.7%, 94.7%) was not significantly different from that of the non-MD group (1, 3, 5 years: 95.0%, 95.0%, 95.0%). Pancreas graft survival in the MD group (1, 3, 5 years: 80.9%, 73.2%, 66.0%) seemed to be slightly lower than that in the non-MD group (1, 3, 5 years: 92.5%, 85.2%, 77.4%), but no statistically significant differences were found between the 2 groups. These results suggest the feasibility of the use of MD for PTx.

AB - In Japan, absolute shortage of donors still continues even after the law allowing organ transplantation from deceased donors came into force in 1997. With the passage of the waiting period after registration for pancreas transplantation (PTx), both deaths and serious cases of diabetic complications necessitating withdrawal of the registration have undoubtedly increased. Therefore, so-called "marginal donor" (MD) has been considered as a potential solution for shortage of donors in Japan. The aim of the present study is to evaluate feasibility of MD in terms of post-PTx outcomes using data from Japan Organ Transplantation Network. A total of 148 PTx were performed from deceased donors in Japan from 2000 to 2012. MD was defined as follows: (1) >45 years old; (2) hemodynamically unstable at harvest using a high-dose dopamine or more than 2 vasopressors; or (3) non-heart-beating status. Postoperative outcomes after PTx were compared between the MD group and the non-MD group. Among the 148 PTx donors, 108 donors (73.0%) satisfied the criteria of MD. Early graft loss of pancreas graft during 3 months post-transplant was observed in 15 patients (10.1%), and the marginality (MD vs non-MD) was not significantly correlated with the early loss of pancreas graft. The overall patient survival of the MD group (1, 3, 5 years: 94.7%, 94.7%, 94.7%) was not significantly different from that of the non-MD group (1, 3, 5 years: 95.0%, 95.0%, 95.0%). Pancreas graft survival in the MD group (1, 3, 5 years: 80.9%, 73.2%, 66.0%) seemed to be slightly lower than that in the non-MD group (1, 3, 5 years: 92.5%, 85.2%, 77.4%), but no statistically significant differences were found between the 2 groups. These results suggest the feasibility of the use of MD for PTx.

UR - http://www.scopus.com/inward/record.url?scp=84899510761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899510761&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2013.11.069

DO - 10.1016/j.transproceed.2013.11.069

M3 - Article

C2 - 24767389

AN - SCOPUS:84899510761

VL - 46

SP - 954

EP - 957

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 3

ER -